Squarepoint
LLY icon

Squarepoint’s Eli Lilly LLY Stock Holding History

Squarepoint’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137M Sell
148,700
-60,100
-29% -$60.9M 0.16% 103
2025
Q4 		$224M Sell
208,800
-129,600
-38% -$124M 0.24% 71
2025
Q3 		$258M Buy
338,400
+106,600
+46% +$79.3M 0.26% 63
2025
Q2 		$181M Buy
231,800
+112,100
+94% +$87.1M 0.19% 96
2025
Q1 		$98.9M Sell
119,700
-132,800
-53% -$111M 0.12% 156
2024
Q4 		$195M Buy
252,500
+173,000
+218% +$143M 0.19% 72
2024
Q3 		$70.4M Buy
79,500
+14,600
+22% +$13.1M 0.11% 164
2024
Q2 		$58.8M Sell
64,900
-5,000
-7% -$4M 0.1% 195
2024
Q1 		$54.4M Buy
69,900
+45,300
+184% +$32.2M 0.09% 227
2023
Q4 		$14.3M Sell
24,600
-4,500
-15% -$2.63M 0.03% 724
2023
Q3 		$15.6M Buy
29,100
+8,400
+41% +$4.33M 0.04% 567
2023
Q2 		$9.71M Buy
20,700
+15,900
+331% +$6.67M 0.03% 695
2023
Q1 		$1.65M Buy
4,800
+3,100
+182% +$1.05M 0.01% 1546
2022
Q4 		$622K Sell
1,700
-900
-35% -$319K ﹤0.01% 2144
2022
Q3 		$841K Sell
2,600
-500
-16% -$158K ﹤0.01% 1876
2022
Q2 		$1M Hold
3,100
– – 0.01% 1596
2022
Q1 		$888K Sell
3,100
-45,000
-94% -$11.6M ﹤0.01% 1660
2021
Q4 		$13.3M Sell
48,100
-700
-1% -$177K 0.04% 429
2021
Q3 		$11.3M Buy
48,800
+600
+1% +$148K 0.03% 457
2021
Q2 		$11.1M Buy
48,200
+34,500
+252% +$6.93M 0.04% 432
2021
Q1 		$2.56M Buy
13,700
+12,400
+954% +$2.43M 0.02% 940
2020
Q4 		$219K Sell
1,300
-500
-28% -$74.7K ﹤0.01% 2448
2020
Q3 		$266K Buy
1,800
+500
+38% +$77.4K ﹤0.01% 1893
2020
Q2 		$213K Buy
+1,300
New +$200K ﹤0.01% 1796
2020
Q1 		– Sell
-4,100
Closed -$539K – 2226
2019
Q4 		$539K Buy
4,100
+2,100
+105% +$243K ﹤0.01% 1731
2019
Q3 		$224K Buy
+2,000
New +$223K ﹤0.01% 2036

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Squarepoint's LLY Position: Q1 2026 in Review

Squarepoint increased its Eli Lilly (LLY) stake by 38% in Q1 2026, buying an estimated $81.6M and bringing the position to 290,181 shares worth $267M. The position accounts for 0.31% of the portfolio, ranked #35.

Squarepoint first reported a position in LLY in Q1 2015 and has held it in 33 quarters since. The position peaked at $346M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Squarepoint held 290,181 shares of Eli Lilly worth $267M as of Q1 2026.
  • Squarepoint bought 80,448 Eli Lilly shares in Q1 2026, an estimated $81.6M.
  • Eli Lilly made up 0.31% of Squarepoint's portfolio in Q1 2026, its #35 holding.
  • Squarepoint first reported a position in Eli Lilly in Q1 2015 and has held it in 33 quarters since.
  • Squarepoint's Eli Lilly position peaked at $346M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.